Nu-Med Plus Inc.
NUMD
Factors that might cause such a difference include, among others, uncertainties relating to general economic and business conditions; industry trends; changes in demand for our products and services; uncertainties relating to customer plans and commitments and the timing of orders received from customers; announcements or changes in our pricing policies or that of our competitors; unanticipated…
Valuation & Multiples
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue
N/A
Net Income (TTM)
-$22K
▲ +17.8% YoY
Op. Margin
–
ROIC
-38.67%
▲ +11.4pp YoY
Cash Flow & Balance Sheet
FCF (FY)
-$48K
▼ -982.3% YoY
Op. Cash Flow (FY)
-$48K
▼ -982.3% YoY
Net Debt
$95K
Cash & Equiv.
$5K
Continue Research
Peers
Surgical & Medical Instruments & Apparatus · Pick stocks to compare with NUMD
Nu-Med Plus (NUMD) in three numbers
Questions about Nu-Med Plus
Is Nu-Med Plus (NUMD) overvalued?
Nu-Med Plus trades at 61.76 times earnings. Intrinsiqq's fair value calculator has no opening value for NUMD, so weigh those multiples against the company's own history and the peers above. See how to tell if a stock is overvalued.
Is Nu-Med Plus a high-quality business?
Nu-Med Plus scores 4 out of 100 on Intrinsiqq's quality score, which makes it a lower-quality business on these measures. The score blends 5 checks computed from SEC filings. Its best check is share count change at 16.3%. The Quality tab shows every check against its target.
Does Nu-Med Plus (NUMD) pay a dividend?
No. Nu-Med Plus (NUMD) does not pay a dividend, and no dividend payment appears anywhere in the filing history we hold. Nor has its share count fallen meaningfully over the last twelve months, so cash is kept in the business. The Dividends tab shows its cash returns.
Source: 10-Q filed 14 Aug 2026 (period ending 30 Jun 2026), SEC. Price: last close 19 Nov 2026. How this is calculated. Sector medians are approximate S&P 500 benchmarks and update periodically. Analysis, not investment advice.
Spot a number that looks wrong? Check it in NUMD's SEC filings or
Download this analysis as a PDF (Pro)
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing NUMD
A free account gives you 10 stocks a day, a watchlist and price alerts.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.